Cocrystal Pharma Inc (COCP)

01:40 AM

What is Noble Financial’s Estimate for COCP Q2 Earnings? - Defense World

01:40 AM

May 15, 2025

Cocrystal Pharma Reports First Quarter 2025 Financial Results an - GuruFocus

May 15, 2025

May 15, 2025

Cocrystal Pharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025

May 15, 2025

Cocrystal Pharma (COCP) Advances CDI-988 for Norovirus Treatment - GuruFocus

May 15, 2025

May 15, 2025

Cocrystal Pharma (COCP) Advances CDI-988 for Norovirus Treatment | COCP Stock News - GuruFocus

May 15, 2025

May 15, 2025

Breakthrough: Cocrystal's Novel Antiviral CDI-988 Demonstrates Superior Activity Against All Major Norovirus Variants - Stock Titan

May 15, 2025

May 10, 2025

Cocrystal Pharma (COCP) Projected to Post Earnings on Monday - Defense World

May 10, 2025

Apr 30, 2025

Norovirus Infection Pipeline: 8+ Leading Companies Advancing - openPR.com

Apr 30, 2025

Apr 26, 2025

Cocrystal Pharma (COCP) Advances Norovirus Drug Candidate CDI-98 - GuruFocus

Apr 26, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 25, 2025

Hepatitis C Virus Infection Pipeline: 20+ Leading Companies - openPR.com

Apr 25, 2025

Apr 25, 2025

Cocrystal Pharma (NASDAQ:COCP) Stock Price Up 3.3% – Here’s Why - Defense World

Apr 25, 2025

Apr 24, 2025

Cocrystal Pharma Advances Norovirus Antiviral Candidate CDI-988 - TipRanks

Apr 24, 2025

Apr 24, 2025

Cocrystal Pharma's Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants - The Manila Times

Apr 24, 2025

Apr 24, 2025

First-Ever Norovirus Treatment Tackles Dominant 2024 Variants: $60B Market Opportunity - Stock Titan

Apr 24, 2025

Apr 23, 2025

Cocrystal Pharma Presents to Investment Community - TipRanks

Apr 23, 2025

Apr 22, 2025

Aytu BioPharma Stock Price, Quotes and Forecasts - Benzinga

Apr 22, 2025

Apr 16, 2025

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference - The Manila Times

Apr 16, 2025

Apr 16, 2025

Cocrystal Pharma CEO to Reveal Latest Developments at Elite Northwest Biotech Summit - Stock Titan

Apr 16, 2025

Apr 15, 2025

Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga

Apr 15, 2025

Apr 11, 2025

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For Vtama® - MarketScreener

Apr 11, 2025

Apr 11, 2025

Strategic Patent Filing Could Transform VTAMA's $233B Market Potential - Stock Titan

Apr 11, 2025

Apr 10, 2025

OTC Markets Hosts Virtual Investor Presentation with Dr. Sam Lee, Co-CEO & President, and Jim Martin, Co-CEO & CFO, of Cocrystal Pharma, with David Bautz, PhD, Senior Analyst at Zacks SCR - Zacks Small Cap Research

Apr 10, 2025

Apr 08, 2025

Cocrystal Pharma Approves 2025 Equity Incentive Plan - TipRanks

Apr 08, 2025

Apr 08, 2025

Influenza Clinical Trials and Studies 2025: EMA, PDMA, FDA - openPR.com

Apr 08, 2025

Apr 07, 2025

Influenza Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Apr 07, 2025

Apr 05, 2025

COCRYSTAL PHARMA Earnings Preview: Recent $COCP Insider Trading, Hedge Fund Activity, and More - Nasdaq

Apr 05, 2025

Apr 04, 2025

Q1 Earnings Forecast for COCP Issued By Zacks Small Cap - Defense World

Apr 04, 2025

Apr 03, 2025

COCP stock touches 52-week low at $1.35 amid market fluctuations By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

COCP stock touches 52-week low at $1.35 amid market fluctuations - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

What is Zacks Small Cap’s Estimate for COCP Q3 Earnings? - Defense World

Apr 03, 2025

Apr 01, 2025

COCP: Norovirus Challenge Study Planned for 2025… - MSN

Apr 01, 2025

Mar 31, 2025

Cocrystal Pharma, Inc. SEC 10-K Report - TradingView

Mar 31, 2025

Mar 31, 2025

Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - TradingView

Mar 31, 2025

Mar 31, 2025

Cocrystal Pharma Pushes Forward with Antiviral Programs Despite $17.5M Loss - Stock Titan

Mar 31, 2025

Mar 27, 2025

Influenza Pipeline: Advancing Innovation with 120+ Trailblazers Developing Transformative Therapies | DelveInsight - openPR.com

Mar 27, 2025

Mar 24, 2025

Cocrystal Pharma Inc expected to post a loss of 53 cents a shareEarnings Preview - TradingView

Mar 24, 2025

Mar 20, 2025

Hepatitis C Virus Infection Pipeline 2025: FDA Updates, Therapy - openPR

Mar 20, 2025

Mar 20, 2025

Cocrystal Pharma (COCP) to Release Earnings on Thursday - Defense World

Mar 20, 2025

Mar 19, 2025

Conduit's Triple-Drug Pipeline Shows Promise for Lupus TreatmentMajor R&D Breakthrough - Stock Titan

Mar 19, 2025

Mar 14, 2025

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing - The Manila Times

Mar 14, 2025

Mar 12, 2025

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines - Investing News Network

Mar 12, 2025

Mar 12, 2025

Life Sciences Investor Forum Agenda Announced for March 13th - Morningstar

Mar 12, 2025

Mar 07, 2025

Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga

Mar 07, 2025

Mar 06, 2025

Cocrystal Pharma to Participate in a Fireside Chat at the - GlobeNewswire

Mar 06, 2025

Mar 06, 2025

Kaltura to Host 2025 Investor Event - The Manila Times

Mar 06, 2025

Mar 06, 2025

Direct Access to Cocrystal Pharma Management: Key Details of Upcoming Zacks Analyst Forum - StockTitan

Mar 06, 2025